ArticleJAAD case reports2021

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient.

John Yeakel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.